3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| PNU112455A hydrochloride | N4-(6-AMINOPYRIMIDIN-4-YL)-SULFANILAMIDE HCL | 21886-12-4 |
| CDK12-IN-2 | 化合物CDK12-IN-2 | 2244987-03-7 |
| MBQ-167 | MBQ 167;MBQ167 | 2097938-73-1 |
| CDK4/6-IN-2 | 1800506-48-2 | |
| CDK12-IN-E9 | CDK12 inhibitor E9 S-isomer | 2020052-55-3 |
| BRD6989 | 642008-81-9 | |
| THZ2 | 1604810-84-5 | |
| PSB-12379 | 1802226-78-3 | |
| CD73-IN-3 | 5-[6-甲基-5-[(1S,2R)-2-丙-2-基环丙基]哒嗪-3-基]-1H-嘧啶-2,4-二酮 | 2375815-63-5 |
| Fadraciclib | CYC-065 | 1070790-89-4 |
| Trilaciclib | 曲拉西利 | 1374743-00-6 |
| Cdc7-IN-1 | CDC7-IN-1 (COMPOUND 13) | 1402055-25-7 |
| MSC2530818 | 1883423-59-3 | |
| CDK9-IN-8 | 2105956-51-0 | |
| (-)-Enitociclib | (-)-BAY-1251152 | 1610358-59-2 |
| CLK1-IN-1 | 2123491-32-5 | 2123491-32-5 |
| CDK8-IN-1 | 1629633-48-2 | |
| THZ531 | 1702809-17-3 | |
| CK7 | CDK2/9 INHIBITOR | 507487-89-0 |
| Bisindolylmaleimide X hydrochloride | BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE) | 145317-11-9 |
| PHA-793887 | 3-甲基-N-[1,4,5,6-四氢-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-C]吡唑-3-基]丁酰胺 | 718630-59-2 |
| CDK8-IN-4 | 1613638-82-6 | |
| CDK12-IN-3 | 2220184-50-7 | |
| Lerociclib dihydrochloride | LEROCICLIB HCL ; G1T38 DIHYDROCHLORIDE ; G1T 38 DIHYDROCHLORIDE | 2097938-59-3 |
| AB-680 | 2105904-82-1 | |
| OP-5244 | 2381268-71-7 | |
| Enitociclib | 1610358-56-9 | 1610358-56-9 |
| Milciclib | PHA-848125 | 802539-81-7 |
| CC-671 | 1618658-88-0 | |
| NVP-2 | 化合物NVP-2 | 1263373-43-8 |
| SRI-29329 | 化合物SRI-29329 | 2086809-58-5 |
| LY3177833 | CS-2783 | 1627696-51-8 |
| DRAK2-IN-1 | 871837-60-4 | |
| CD73-IN-4 | 化合物CD73-IN-4 | 2216764-29-1 |
| AZD4573 | 2057509-72-3 | |
| THAL-SNS-032 | 2139287-33-3 | |
| Voruciclib | 1000023-04-0 | |
| Mevociclib | SY-1365 | 1816989-16-8 |
| Atuveciclib S-Enantiomer | 250279-81-1 | |
| PROTAC CDK2/9 Degrader-1 | 2408641-24-5 | |
| CPS2 | 化合物 CPS2 | 2756741-90-7 |
| dCeMM2 | 化合物 DCEMM2 | 296771-07-8 |
| TNIK-IN-3 | 化合物TNIK-IN-3 | 2754265-25-1 |
| Eciruciclib | 化合物 ECIRUCICLIB | 1868086-40-1 |
| AUZ 454 | K03861 | 853299-07-7 |
| BMS-265246 | BMS265246 | 582315-72-8 |
| Ribociclib hydrochloride | 7-环戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺盐酸盐 | 1211443-80-9 |
| AZ5576 | 化合物AZ5576 | 2751721-40-9 |
| CDK9-IN-7 | 2369981-71-3 | |
| CKI-7 free base | CKI-7 | 120615-25-0 |
| CDK4/6-IN-6 | 2380321-51-5 | |
| WEE1-IN-5 | 化合物DEBIO-0123 | 2243882-74-6 |
| NG 52 | 2-[[6-[(3-氯苯基)氨基]-9-异丙基-9H-嘌呤-2-基]氨基]乙醇 | 212779-48-1 |
| CVT-313 | CVT 313 | 199986-75-9 |
| Ipivivint | 1481617-15-5 | |
| SY-5609 | 7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈 | 2417302-07-7 |
| Ribociclib succinate | LEE011 琥珀酸盐 | 1374639-75-4 |
| HS38 | 2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide | 1030203-81-6 |
| Palbociclib-d8 | 帕博西尼-D8 | 1628752-83-9 |
| AT7519 | 4-[(2,6-二氯苄基)氨基]-N-4-哌啶1H-吡唑-3-羧胺 | 844442-38-2 |
| AT7519 Hydrochloride | N-(4-哌啶基)-4-(2,6-二氯苄氨基)-1H-吡唑-3-羧胺盐酸盐 | 902135-91-5 |
| NCT02 | 2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺 | 790245-61-3 |
| Aminopurvalanol A | 220792-57-4 | |
| CDKI-73 | CS-2259 | 1421693-22-2 |
| NSC 107512 | 化合物 NSC 107512 | 22242-89-3 |
| Abemaciclib | 阿贝西利 | 1231929-97-7 |
| CDK9-IN-2 | N2'-(反式-4-氨基环己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-联吡啶]-2',6-二胺 | 1263369-28-3 |
| Riviciclib hydrochloride | P276-00 | 920113-03-7 |
| CDK7/12-IN-1 | 化合物 CDK7/12-IN-1 | 2654075-94-0 |
| SR-4835 | 2387704-62-1 | |
| CFTR corrector 4 | 1918142-34-3 | |
| DB1113 | INDEX NAME NOT YET ASSIGNED | 2769753-53-7 |
| KH-CB20 | 1354448-60-4 | |
| Longdaysin | 9H-Purin-6-aMine, 9-(1-Methylethyl)-N-[[3-(trifluoroMethyl)phenyl]Methyl]- | 1353867-91-0 |
| FN-1501 | 1429515-59-2 | 1429515-59-2 |
| (E/Z)-Zotiraciclib hydrochloride | 化合物 (E/Z)-ZOTIRACICLIB HYDROCHLORIDE | 1321626-25-8 |
| Indirubin-3′-oxime | (2Z,3E)-3-(羟基亚氨基)-[2,3'-联吲哚啉亚基]-2'-酮 | 667463-82-3 |
| NGR peptide | 细胞穿膜肽 NGR PEPTIDE | 651328-78-8 |
| NVP 231 | NVP-231 | 362003-83-6 |
| Anacetrapib | 安塞曲匹 | 875446-37-0 |
| Dalcetrapib | CETP抑制剂 | 211513-37-0 |
| Torcetrapib | 托彻普 | 262352-17-0 |
| Evacetrapib (LY2484595) | 反式-4-[[(5S)-5-[[[3,5-双(三氟甲基)苯基]甲基](2-甲基-2H-四氮唑-5-基)氨基]-2,3,4,5-四氢-7,9-二甲基-1H-1-苯并氮杂卓-1-基]甲基]环己烷羧酸 | 1186486-62-3 |
| AZD7507 | CS-2850 | 1041852-85-0 |
| Sotuletinib | BLZ945 | 953769-46-5 |
| c-Fms-IN-3 | 4-氰基-N-[4-(4-甲基-1-哌嗪基)-2-(4-甲基-1-哌啶基)苯基]-1H-吡咯-2-甲酰胺 | 885704-21-2 |
| c-Fms-IN-13 | 化合物C-FMS-IN-13 | 885704-58-5 |
| c-Fms-IN-1 | 885703-64-0 | |
| BPR1R024 | 2503015-75-4 | |
| Navocaftor | 2159103-66-7 | |
| GLPG2451 | 2055015-61-5 | |
| Rintodestrant | 2088518-51-6 | |
| HS-243 | 848249-10-5 | |
| Icenticaftor | 3-氨基-6-甲氧基-N-[(2S)-3,3,3-三氟-2-羟基-2-甲基丙基]-5-(三氟甲基)-2-吡啶甲酰胺 | 1334546-77-8 |
| Elexacaftor | 2216712-66-0 | |
| Olacaftor | 1897384-89-2 | |
| Narazaciclib | 8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 | 1357470-29-1 |
| RGB-286638 | N-[1,4-二氢-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-吗啉基脲盐酸盐 | 784210-87-3 |
| c-Fms-IN-8 | 1255303-58-2 | |
| Bamocaftor | 2204245-48-5 | 2204245-48-5 |
联系方式
